logo

Bristol-Myers Squibb Co. (BMY) Stock: A Year of Decreases and Increases

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Bristol-Myers Squibb Co.’s current trading price is -36.34% away from its 52-week high, while its distance from the 52-week low is 1.52%. The stock’s price range for this period has been between $43.33 and $69.10 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 12.0 million for the day, a number notably lower than the average daily volume of 15.91 million over the last three months.

The market performance of Bristol-Myers Squibb Co.’s stock has been turbulent in recent times. Over the last year, the company’s stock reached its highest point at $69.10 on 05/11/23, while the lowest value for the same duration was $43.33 on 05/02/24.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Bristol-Myers Squibb Co. (BMY) has experienced a quarterly decline of -9.69% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 89.17B and boasts a workforce of 34100 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 50.36, with a change in price of -6.32. Similarly, Bristol-Myers Squibb Co. recorded 16,059,366 in trading volume during the last 100 days, posting a change of -12.56%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for BMY stands at 3.48. Similarly, the long-term debt-to-equity ratio is also 3.10.

BMY Stock Stochastic Average

Bristol-Myers Squibb Co.’s raw stochastic average for the past 50 days is presently 5.61%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 7.87%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 6.01% and 4.17%, respectively.

BMY Stock Price Performance Analysis

The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. The metric has seen a significant loss of -14.27% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -14.22%. Over the past 30 days, the price of BMY has leaped by -14.42%. And in the last five days, it has fallen by -1.92%.

Most Popular